Skye Bioscience (SKYE) Liabilities and Shareholders Equity (2012 - 2026)
Skye Bioscience (SKYE) posted Liabilities and Shareholders Equity of $11.03 million for Q2 2026, down 78.8% from $52.16 million a year earlier and down 43.2% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience's Liabilities and Shareholders Equity came in at $28.31 million, down 61.1% from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 60.3% (FY2020 to FY2025).
- In prior years, Skye Bioscience's Liabilities and Shareholders Equity was $72.76 million in FY2024 (+509.4%), $11.94 million in FY2023 (+31.1%), $9.11 million in FY2022 (-7.5%) and $9.86 million in FY2021 (+268.9%).
- The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q2 2023.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last six quarters, with growth averaging 75.1% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2024, with growth of 509.4%; the weakest was Q2 2026, with a decline of 78.8%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $19.42 million (Q1 2026), $28.31 million (Q4 2025) and $41.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 11.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.03 Mn |
| Mar 31, 2026 | 19.42 Mn |
| Dec 31, 2025 | 28.31 Mn |
| Sep 30, 2025 | 41.32 Mn |
| Jun 30, 2025 | 52.16 Mn |
| Mar 31, 2025 | 64.79 Mn |
| Dec 31, 2024 | 72.76 Mn |
| Sep 30, 2024 | 81.54 Mn |
| Jun 30, 2024 | 87.26 Mn |
| Mar 31, 2024 | 94.84 Mn |
| Dec 31, 2023 | 11.94 Mn |
| Sep 30, 2023 | 15.60 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 7.21 Mn |
| Dec 31, 2021 | 9.86 Mn |
| Sep 30, 2021 | 11.69 Mn |
API Access
Skye Bioscience Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();